Departamento de Endocrinología y Metabolismo de Lípidos


Dr. Francisco Javier Gómez Pérez

(55) 5487 0900 Ext. 2405 y 2406
francisco.gomezp@incmnsz.mx

GRADO ACADÉMICO: Medico Cirujano
CATEGORÍA: Investigador en Ciencias Médicas C
SISTEMA NACIONAL DE INVESTIGADORES Nivel III

 

LINEAS DE INVESTIGACIÓN

Complicaciones microvasculares de la diabetes.

Oftalmopatía Tiroidea.

Tratamientos para la DM.

Enfermedades Neurohipofisiarias.


PUBLICACIONES RELEVANTES DE LOS ULTIMOS 5 AÑOS

Miranda -Gardtmo LM, Gómez-Pérez FJ, Rull-Rodrigo JA. Improvement of autoimmune hypoglycemia by decresing circulating free insulin concentrations with metformin. Endocrine Practice 2008;14(4):511-513.

Cuevas-Ramos D, Almeda-Valdes P, Aguilar-Salinas CA, Cuevas-Sosa AA, Gómez- Pérez FJ. The Role of Fibroblast Growth factor 21(FGF21) on energy balance, glucose and lipid metabolism. Current Diabetes Rev.2Q09;5:216-220.

Cuevas-Ramos D, Almeda-Valdes P, Gómez-Pérez FJ, Meza-Arana CE, Cruz-Bautista I, Arellano-Campos O, Navarrete-Lopez M, Aguilar-Salinas CA. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels. European Journal of Endocrinology 2010;163:469-477.

Gómez-Pérez FJ, Aguilar-Salinas CA, Almeda-Valdes P, Cuevas-Ramos D, Lerman- Garber I, Rull JA. HbAlc for the diagnosis of diabetes mellitus in a developing country. A position article. Archives of medical Research 2010;41:302-308.

Gómez-Pérez FJ, Rojas R, Villalpando S, Barquera S, Rull JA, Aguilar-Salinas CA. Prevention of cardiovascular disease based on lipid lowering treatment: a challenge for the Mexican health system. Salud Publica de Mexico 2010;52 (suppl l}:54-62.

Gómez-Pérez FJ. Diabetes en el paciente geriatrico. Revista de investigacion CImica 2010;62(4):301.

Cuevas-Ramos D, Almeda-Valdes P, Arvizu J, Mata LE, Morales B, Gabilondo B, Vilatoba M, Correa R, Gabilondo-Navarro F, Mehta R, Aguilar-Salinas CA, Alberu J,Gomez-Perez FJ. Association of the metabolic syndrome and long-term renal function in kidney donors. Transplantation Proceedings 2011;43:1601-1606.

Duran-Pérez EG, Almeda-Valdes P. Cuevas-Ramos D, Campos-Barrera E, Muñoz- Hernández L, Gómez-Pérez FJ. Treatment of metabolic syndrome shows progresion of diabetic nephropathy. Metabolic Syndrome and Related Disorders 2011;9(6): 483-489.

Cuevas-Ramos D, Almeda-Valdes P, Meza-Arana CE, Brito-Cordova GX, Gómez-Pérez FJ, Mehta R, Oseguera-Moguel J, Aguilar-Salinas CA. Exercise increase serum fibroblast growth factor (FGF21)Levels. PLoS One 2012;7(5):e38022.

Cuevas-Ramos D, Aguilar- Salinas CA, Gómez-Pérez FJ. Metabolic actions of fibroblast growth factor 21. Current Opinion Pediatrics 2012 Ago;24(4):523-529.

Pérez G. Almeda-Valdes P, Cuevas-Ramos D, Juárez-Comboni SC, Higuera-Calleja J, Gómez-Pérez FJ. Hypopliysitis autoimmune. Case series and literature review. Gac. Med. Mex 2013;149(2):229-236.

Cuevas-Ramos D, Almeda-Valdes P, Chavez-Manzanera EA, Meza-Arana CE, Brito- Cordova GX, Mehta R, Perez-Mendez O, Gomez-Perez FJ. Effect of tomato consumption on high.density lipoproteina colesterol level: a randomzed, single-blinded, controlled clinical trial. Diabetes, Metabolic Syndrome and Obesity: Targets and Theraphy 2013;3:6 263-273.

Almeda-Valdés P, Cuevas-Ramos D, Mehta R, Muñóz-Hernández L, Cruz-Bautista I, Pérez-Méndez O, Tusié-Luna MT, Gómez-Pérez FJ. PajukantaP, Matikainene N, Aguilar-Salinas CA. Factors associated with postprandial lipemia and apolipoproteína V levels in individuals with familial combined hyperlipidemia. BMC Endocrine Disorders 2014;14(1):90.